Wilbert S. Aronow MD is Professor of Medicine at New York Medical College/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 13 books and is author or co-author of 1,439 papers, 283 commentaries or Letters to the Editor, and 999 abstracts and is presenter or co-presenter of 1,355 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 109 editorial boards of medical journals, co-editor of 2
Wilbert S. Aronow MD is Professor of Medicine at New York Medical College/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 13 books and is author or co-author of 1,439 papers, 283 commentaries or Letters to the Editor, and 999 abstracts and is presenter or co-presenter of 1,355 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 109 editorial boards of medical journals, co-editor of 2 journals, deputy editor of 1 journal, executive editor of 3 journals, associate editor for 9 journals, and guest editor for 7 other medical journals. He has received each year from 2001-2015 an outstanding teacher and researcher award from the medical residents and from 2001-2015 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor's Research Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, 2013, and 2014, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012. He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure , co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and is currently a member of the writing group of the ACC/AHA guideline for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum. He was a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis. He is currently a member of the Board of Directors of the ASPC and a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee.
Lance D. Dworkin, M.D., is Professor of Medicine, Vice Chairman of Medicine for Research, Academic Affairs & Ethics, and Director of the Division of Kidney Disease and Hypertension at Brown. He has directed the kidney program here since he first joined the faculty at Brown in 1993. During his tenure, the Kidney and Hypertension Division greatly expanded, from three to now fifteen full-time faculty, and also includes about twenty allied clinical faculty in private practice. From 2008 until 2010, Dr. Dworkin served as Interim Chair of Medicine at Brown. Dr. Dworkin has served on a number
Lance D. Dworkin, M.D., is Professor of Medicine, Vice Chairman of Medicine for Research, Academic Affairs & Ethics, and Director of the Division of Kidney Disease and Hypertension at Brown. He has directed the kidney program here since he first joined the faculty at Brown in 1993. During his tenure, the Kidney and Hypertension Division greatly expanded, from three to now fifteen full-time faculty, and also includes about twenty allied clinical faculty in private practice. From 2008 until 2010, Dr. Dworkin served as Interim Chair of Medicine at Brown. Dr. Dworkin has served on a number of University committees, including the FEC, biomedical faculty council, and the President's Science Council. He also serves on a large number of Departmental and Hospital committees, including the Lifespan Conflict of Interest Committee. Dr. Dworkin maintains a clinical practice caring for patients with hypertension and/or kidney disease in both the inpatient and outpatient settings. He has an interest in global health in nephrology and has developed close collaborations with kidney programs in Kenya and in China; he is an honorary Professor of Medicine at Nanjing University. He conducts laboratory research on the mechanisms of progressive kidney failure and its prevention. He is also a specialist in hypertension and the senior leader for the CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial, a large, multicenter, randomized clinical trial funded by NHLBI which is comparing outcomes in patients with atherosclerotic renal artery stenos is treated medically with those that also receive stent revascularization. Dr. Dworkin has published on a variety of topics in kidney disease and hypertension, including mechanisms of kidney injury in hypertension and on outcomes and therapy of patients with renal vascular disease. He lectures frequently locally, nationally and internationally.
Dr. Michelle Albert is a graduate of Haverford College at University of Rochester School of Medicine. Dr. Albert completed her residency (1993-1997) and chief residency (1997-1998) in Internal Medicine at Columbia University where she also served as Instructor of Medicine. She then completed Cardiovascular Clinical and Research Fellowship at the Brigham and Women's Hospital and Harvard Medical School (1998-2002), where she was subsequently an Associate Professor in Medicine and Director of Behavioral and Neurocardiovascular Cardiology. Dr. Albert served as the Vivian Beaumont Allen Endowed Chair and Professor of Medicine at Howard University, Washington DC, where she was Chief of Cardiovascular
Dr. Michelle Albert is a graduate of Haverford College at University of Rochester School of Medicine. Dr. Albert completed her residency (1993-1997) and chief residency (1997-1998) in Internal Medicine at Columbia University where she also served as Instructor of Medicine. She then completed Cardiovascular Clinical and Research Fellowship at the Brigham and Women's Hospital and Harvard Medical School (1998-2002), where she was subsequently an Associate Professor in Medicine and Director of Behavioral and Neurocardiovascular Cardiology. Dr. Albert served as the Vivian Beaumont Allen Endowed Chair and Professor of Medicine at Howard University, Washington DC, where she was Chief of Cardiovascular Medicine. Concurrently, Dr. Albert is also an Adjunct Professor of Medicine at Johns Hopkins School of Medicine. Dr. Albert has a national reputation in the research domain where her publications focus on surrogate biomarkers of cardiovascular disease risk and chronic psychological stress, with a focus on the life course perspective in women and vulnerable populations. A recipient of several research awards, including R01 funding from the NIH, Dr. Albert enjoys mentoring trainees at all levels across the United States and was nominated for the competitive 2011-2012 Excellence in Mentoring Award at Harvard Medical School. She is a recipient of Woman's Day Magazine's Red Dress Award (2014) and received the Haverford College Alumni Award for service to society (2015). Dr. Albert transitioned to University of California at San Francisco in January 2015 where she is Professor in Medicine and founding director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaRDiseasE (NURTURE Center), a new translational research Center with an overarching theme of 'the biology of adversity', a non-traditional area in cardiovascular research focused on understanding the biology of the interplay between vulnerable populations, psychosocial determinants of health and biomarkers of cardiovascular disease risk with outcome as a strategy to inform new interventions.
Dr. David Rae Harder began his scientific career at the Medical College of Wisconsin (MCW) where he completed his PhD degree in the Department of Biophysics in 1976. After a brief post-doctoral fellowship at the University of Virginia, Charlottesville, he joined East Tennessee University as an Assistant Professor of Physiology. During this period, he made his first seminal discovery in cardiovascular biology (Harder and Coulson, 1979). He identified functional estrogen receptors on vascular smooth muscle of the coronary artery, and demonstrated its role in modifying inward Ca2+ current in coronary arterial smooth muscle and control of blood flow to the
Dr. David Rae Harder began his scientific career at the Medical College of Wisconsin (MCW) where he completed his PhD degree in the Department of Biophysics in 1976. After a brief post-doctoral fellowship at the University of Virginia, Charlottesville, he joined East Tennessee University as an Assistant Professor of Physiology. During this period, he made his first seminal discovery in cardiovascular biology (Harder and Coulson, 1979). He identified functional estrogen receptors on vascular smooth muscle of the coronary artery, and demonstrated its role in modifying inward Ca2+ current in coronary arterial smooth muscle and control of blood flow to the heart. This was a major contribution to our understanding of coronary physiology and explains some of the differences between gender and cardiac function. In 1983, he was recruited back to MCW as an Associate Professor in Neurology and Physiology and quickly became the Director of Neurology Research at MCW. During this period, he made his second seminal discovery, which was the underlying mechanism associated with blood flow autoregulation (Harder, 1984). This paper is a citation classic and has been largely responsible for our understanding of the mechanism of blood flow autoregulation in the brain, kidney and other vascular beds. These organs are knownto maintain a relatively constant blood flow despite large changes in arterial pressure. Importantly, this work has stood the test of time, and has been confirmed by several leading laboratories across the world. The discovery has spawned mechanistic studies into the second messenger systems involved such as DAG, PKC, 20-HETE and other metabolites of poly unsaturated fatty acids (PUFAs). In addition, this work has initiated many tangential studies defining the role of membrane stretch in triggering this response. Studies are still being performed in defining mechanisms triggering this response including TRP channels, Ca2+ influx, Na-H exchange and numerous other signaling events (Roman, 2002). He received the AHA established investigator award for this work, and was chosen for the Veterans Administration Research Career Scientist Award. In 1987, he was elected to the Royal Society of Medicine in London, and was promoted to full Professor with tenure in the Department of Physiology at MCW. Perhaps, his most prolific work was yet to come in hindsight since his trajectory over the next five years was simply put, 'meteoric'. In 1990, he received the Method to Extend Research in Time (MERIT) award from NIH, which is given to select individuals with outstanding track records of sustained funding. Within two years, he became the founding director of the Cardiovascular Research Center (CVRC) at the MCW. At that time, the Center was the first of its kind in the school, and Dr. Harder again blazed the trails for others to follow in the school. At present several centers in the school are modeled after the CVRC, and during Dr. Harder's tenure the CVC had gained worldwide reputation as a premier cardiovascular research enterprise. During this period, he made a third seminal discovery where he identified epoxicoicosatrienoic acids (EETs), products of arachidonic acid metabolism were potent inducers of angiogenesis (Zhang and Harder, 2002). This finding unleashed the potential use of EETs for ischemic related stroke prevention, and has greatly contributed to our understanding of the role of the EETs in the regulation of the vascular reactivity in health and disease(Campbell et al., 1996; Fisslthaler et al., 1999). Most, if not all, of his findings have been published in high impact journals like Nature, Circulation Research and Stroke. From 1999-2004, he served as the Editor in Chief for the American Journal of Physiology, Heart and Circulation, and chaired the AHA publications committee. He was also elected as fellow in the AHA council for high blood pressure research and council on circulation. His EETs work, especially the analgesic effect finding of 14,15-EETs, has led to the development of anti-pain drugs devoid of addiction (Terashvili et al., 2008). He singlehandedly drove the development of this anti-pain drug, which has now cleared Phase I studies in the clinic. This remarkable achievement was done at a time when translational research was not the focus of NIH. It again shows how far ahead Dr. Harder was of his times. Subsequent studies (Terashvili et al., 2012) from his lab have revealed the translational aspect of his work with direct impact on health outcome. Dr. Harder is an institutional leader whose opinion and time is highly valued. He currently serves as the Associate Dean for Mentoring at MCW, and is the Director of Mentoring, CTSI at MCW. He takes his mentoring responsibilities seriously and is highly generous with his time. He also wants to disseminate knowledge to others, and help others whenever possible. This is highlighted by the Course in Grant Writing that he directs for CTSI each year. He has instituted several initiatives on campus that have taken one shape or another, and helped many individuals at different levels in the institution. He is highly respected, and regarded, and shows the rare combination of class and brilliance. Finally, we will highlight his latest research that continues to make waves. In the last 2-3 years, Dr. Harder and Dr. Ramani Ramchandran, PhD (Professor, Pediatrics, Division of Development Biology, Patrick J. and Margaret G. McMahon Chair of Obstetrics and Gynecology, Vice Chair for Research, Department of Obstetrics and Gynecology- MCW) have interacted at a peer level due to their mutual interests in solving big questions in biology. Dr. Harder introduced Dr. Ramchandran to astrocytes, the glia cell in the brain, which is the focus of his cerebral autoregulation work. Dr. Ramchandran is a vascular biologist by training with deep interest in its application to disease. When Dr. Harder mentioned astrocytes, Dr. Ramchandran was intrigued, and over the course of meetings, they came up with testable ideas. They hypothesized that astrocytes were not reactionary to tumor cells like most believed but rather that they have properties that induce tumor cells to grow, proliferate and migrate to distant sites. Indeed, they had identified that neonatal astrocytes secrete proteins that make breast, lung and sarcoma tumor cells highly metastatic in vivo and in vitro (Wang et al., 2013). This work is now beginning to provide glimpses into the biology of metastasis, which was previously unappreciated. Once again, Dr. Harder finds himself in the middle of a novel landmark discovery in biology. Even now, Dr. Harder continues to maintain active NIH funding, and his ability to keep sustained funding for the last 35 plus years of research is truly a feat in itself.
Armando Tellez, M.D. received his medical degree from Universidad de Monterrey in Monterrey, Nuevo Leon, Mexico. Dr. Tellez has dedicated his professional career 100% to research, specifically in the preclinical field. The focus of his research are intravascular device and imaging technology evaluation, atherosclerosis, vascular biology and animal models of disease. He started his career in the Research Institute in The Methodist Hospital in Houston, Texas. He continue his research in the Skirball Center of Innovation in the Cardiovascular Research Foundation in New York. He is currently the Scientific Director of Alizee Pathology, a histopathology center focused on preclinical research
Armando Tellez, M.D. received his medical degree from Universidad de Monterrey in Monterrey, Nuevo Leon, Mexico. Dr. Tellez has dedicated his professional career 100% to research, specifically in the preclinical field. The focus of his research are intravascular device and imaging technology evaluation, atherosclerosis, vascular biology and animal models of disease. He started his career in the Research Institute in The Methodist Hospital in Houston, Texas. He continue his research in the Skirball Center of Innovation in the Cardiovascular Research Foundation in New York. He is currently the Scientific Director of Alizee Pathology, a histopathology center focused on preclinical research and cardiovascular device evaluation in Thurmont, Maryland.
Dr. Ramiro Sanchez is a Head at University Hospital Fundacion Favaloro in the division of Hypertension and Metabolic Unit. Dr. Sanchez is serving as a Professor in Internal Medicine at Favaloro University Medical School. He is also the Director of Hypertension Specialist Career, Favaloro University. He is a member of International Society of Hypertension, European Society of Hypertension, Argentina Society of Nephrology, American Society of Hypertension. His academic positions: Past-President Latin America Society of Hypertension (LASH), President of Board of Presidents LatinAmerica Society of Hypertension, Officer at Large International Society of Hypertension (2004-2008) Fellow of American Heart Association.
Dr. Ramiro Sanchez is a Head at University Hospital Fundacion Favaloro in the division of Hypertension and Metabolic Unit. Dr. Sanchez is serving as a Professor in Internal Medicine at Favaloro University Medical School. He is also the Director of Hypertension Specialist Career, Favaloro University. He is a member of International Society of Hypertension, European Society of Hypertension, Argentina Society of Nephrology, American Society of Hypertension. His academic positions: Past-President Latin America Society of Hypertension (LASH), President of Board of Presidents LatinAmerica Society of Hypertension, Officer at Large International Society of Hypertension (2004-2008) Fellow of American Heart Association.
Hiroshi Yoshida, M.D. is graduated from Nippon Medical School (Bsc) obtained MD and subsequently entered the Department of Surgery in 1986. From 1988 to 1992, He attended Postgraduate course in Department of Surgery, Nippon Medical School and obtained PhD. In 1992, He was appointed clinical fellow of the Department of Surgery, Nippon Medical School. In 2003, He was appointed assistant professor and, in 2005, associated professor of the Department of Surgery, Nippon Medical School. In 2010, He was appointed associated professor of the Department of Surgery, Nippon Medical School Tama Nagayama Hospital. In 2011, he was appointed Chief and Clinical
Hiroshi Yoshida, M.D. is graduated from Nippon Medical School (Bsc) obtained MD and subsequently entered the Department of Surgery in 1986. From 1988 to 1992, He attended Postgraduate course in Department of Surgery, Nippon Medical School and obtained PhD. In 1992, He was appointed clinical fellow of the Department of Surgery, Nippon Medical School. In 2003, He was appointed assistant professor and, in 2005, associated professor of the Department of Surgery, Nippon Medical School. In 2010, He was appointed associated professor of the Department of Surgery, Nippon Medical School Tama Nagayama Hospital. In 2011, he was appointed Chief and Clinical Professor of the Department of Surgery, Nippon Medical School Tama Nagayama Hospital. In 2014, he was appointed Assistant Director of the Nippon Medical School Tama Nagayama Hospital.
Dr. Pingjin Gao is a Professor of the Department of Hypertension at Ruijin Hospital Jiaotong University School of Medicine, the Vice Director of Shanghai Institute of Hypertension, and Director of Shanghai Key Laboratory of Vascular Biology Shanghai. Dr. Gao's main research interests are: Diagnosis and therapy of intractable hypertension, including screening for secondary hypertension, The establishment and application of genetic hypertension resources (Dr Gao's team has collected many samples, including hypertensive patients, normotensive subjects, nuclear families and sib-pairs), The mechanisms of vascular remodelling in hypertension, her main focus being the role of inflammatory phenotype of perivascular adipocytes in vascular structure
Dr. Pingjin Gao is a Professor of the Department of Hypertension at Ruijin Hospital Jiaotong University School of Medicine, the Vice Director of Shanghai Institute of Hypertension, and Director of Shanghai Key Laboratory of Vascular Biology Shanghai. Dr. Gao's main research interests are: Diagnosis and therapy of intractable hypertension, including screening for secondary hypertension, The establishment and application of genetic hypertension resources (Dr Gao's team has collected many samples, including hypertensive patients, normotensive subjects, nuclear families and sib-pairs), The mechanisms of vascular remodelling in hypertension, her main focus being the role of inflammatory phenotype of perivascular adipocytes in vascular structure and function, Screening and discovery of new biomarkers in vascular injury.
Graduate in Medicine by Faculty of Medicine of University of Porto, Portugal, in 1995 Doctorate in Clinical and Health Services Research in 2014, in the Faculty of Medicine of University of Porto, Portugal Specialist in General & Family Medicine since 2002 I practiced medicine as family physician in St John's Health Centre, Porto, Portugal from 2003 to 2014; Actually, I practice at Private Hospital of Gaia, Portugal. I work in Faculty of Medicine of University of Porto since 2004. I'm now an assistant professor of Department of Social Sciences and Health, teaching Preventive Medicine, Primary Health Care and General & Family Medicine in
Graduate in Medicine by Faculty of Medicine of University of Porto, Portugal, in 1995 Doctorate in Clinical and Health Services Research in 2014, in the Faculty of Medicine of University of Porto, Portugal Specialist in General & Family Medicine since 2002 I practiced medicine as family physician in St John's Health Centre, Porto, Portugal from 2003 to 2014; Actually, I practice at Private Hospital of Gaia, Portugal. I work in Faculty of Medicine of University of Porto since 2004. I'm now an assistant professor of Department of Social Sciences and Health, teaching Preventive Medicine, Primary Health Care and General & Family Medicine in the first cycle of studies. Trainer of medical residents since 2008. I'm senior researcher in the CINTESIS - Center for Health Technology and Services Research, since 2015. My research interests are doctor-patient relationship, health literacy, preventive medicine (cardiovascular diseases and sexually transmitted infections), and ethics.
Dr. Nijasri C. Suwanwela is a Professor in Neurology at the Chulalongkorn University in Thailand. She received her medical degree and completed her residency in neurology from Chulalongkorn University. She had her fellowship training in cerebrovascular disease at the Massachusetts General Hospital in Boston, USA. She also received a Certificate in Neurosonology from the American Society of Neuroimaging. Dr. Suwanwela pioneered the 'Stroke Fast Track' program and the use of thrombolysis in acute ischemic stroke in Thailand. She is presently the Head of Division of Neurology, Chulalongkorn University and Director of Chulalongkorn Comprehensive Stroke Center. She
Dr. Nijasri C. Suwanwela is a Professor in Neurology at the Chulalongkorn University in Thailand. She received her medical degree and completed her residency in neurology from Chulalongkorn University. She had her fellowship training in cerebrovascular disease at the Massachusetts General Hospital in Boston, USA. She also received a Certificate in Neurosonology from the American Society of Neuroimaging. Dr. Suwanwela pioneered the 'Stroke Fast Track' program and the use of thrombolysis in acute ischemic stroke in Thailand. She is presently the Head of Division of Neurology, Chulalongkorn University and Director of Chulalongkorn Comprehensive Stroke Center. She is also the vice president of the Thai Stroke Society and Secretary General of the Neurological Society of Thailand. Dr. Suwanwela's major research interests are about acute stroke management, neurosonology and pathophysiology of atherothrombotic stroke especially among Asians. She published many articles in international peer-reviewed journals. She also delivered many local and international lectures.
Dr. Stefano Omboni is a physician and cardiologist. He is expert in blood pressure monitoring and telemonitoring, arterial hypertension, cardiovascular disease and telemedicine. His expertise also extends to clinical physiology and pharmacology. He is currently Director of the Italian Institute of Telemedicine, a research center located nearby Varese (Italy), dedicated to the research and development of new telemedicine solutions for the prevention and management of chronic diseases. Dr. Omboni is member of the Guideline Writing Committee and the Working Group of Blood Pressure Monitoring of the Italian and European Society of Hypertension, and member of the Italian, European and International
Dr. Stefano Omboni is a physician and cardiologist. He is expert in blood pressure monitoring and telemonitoring, arterial hypertension, cardiovascular disease and telemedicine. His expertise also extends to clinical physiology and pharmacology. He is currently Director of the Italian Institute of Telemedicine, a research center located nearby Varese (Italy), dedicated to the research and development of new telemedicine solutions for the prevention and management of chronic diseases. Dr. Omboni is member of the Guideline Writing Committee and the Working Group of Blood Pressure Monitoring of the Italian and European Society of Hypertension, and member of the Italian, European and International Society of Hypertension and of the American Telemedicine Society. He has co-authored hundreds of scientific publications and has given lectures in several scientific meetings.
Dr. Joao H. Costa Silva is Adjunct Professor of Human Physiology and Farmacology at Federal Univesity of Pernambuco - UFPE (Vitoria de Santo Antao-PE, Brazil), a full member of UFPE's doctoral program and leader of research group 'Cardio-respiratory Control and Phenotypic Plasticity'. Dr. Silva is pharmacist and received his habilitation in Pharmacy at UFPE in 2005 and obtained a positive evaluation as Adjunct Professor in 2010. He received his master degree in Pharmaceutical Sciences at UFPE (2006) and his Ph.D. in Physiology at University of Sao Paulo (2010). Before, he had studied at L'Universite Claude Bernard - Lyon I, France
Dr. Joao H. Costa Silva is Adjunct Professor of Human Physiology and Farmacology at Federal Univesity of Pernambuco - UFPE (Vitoria de Santo Antao-PE, Brazil), a full member of UFPE's doctoral program and leader of research group 'Cardio-respiratory Control and Phenotypic Plasticity'. Dr. Silva is pharmacist and received his habilitation in Pharmacy at UFPE in 2005 and obtained a positive evaluation as Adjunct Professor in 2010. He received his master degree in Pharmaceutical Sciences at UFPE (2006) and his Ph.D. in Physiology at University of Sao Paulo (2010). Before, he had studied at L'Universite Claude Bernard - Lyon I, France (2006-2007). He became full member of Brazilian Society of Physiology in 2010 and American Physiological Society in 2011. His main research interests are hypertension, metabolic disease, life style, phenotypic plasticity, neural control of the cardio-respiratory physiology, experimental models of maternal diet-induced hypertension and pharmacological therapy. His research articles have been published in international peer-reviewed journals, including Nutrition, Metabolism and Cardiovascular Diseases; American Journal of Physiology-Regulatory, Integrative and Comparative Physiology; British Journal of Nutrition; Journal of Physiology; The Journal of Nutrition; Journal of Neurophysiology; Evidence-Based Complementary and Alternative Medicine; European Journal of Nutrition; Frontiers in Physiology; Journal of Ethnopharmacology; Plos One; Life Sciences and Molecules.
Dr. Mustali M. Dohadwala is the Medical Director and sole practitioner of Heartsafe LLC, a private practice located in North Andover that has been providing a vast array of cardiovascular services to the Merrimack Valley Community for many years. Dr. Dohadwala and Heartsafe are acclaimed for overseeing operations of a Nuclear Cardiology laboratory that was first-in-the-area to be accredited by the Intersocietal Accreditation Commission. At Heartsafe, his chief goal is to provide exceptional care without exception. He graduated with honors from a liberal arts college in North Texas, Austin College. He then acquired a medical degree from The Medical
Dr. Mustali M. Dohadwala is the Medical Director and sole practitioner of Heartsafe LLC, a private practice located in North Andover that has been providing a vast array of cardiovascular services to the Merrimack Valley Community for many years. Dr. Dohadwala and Heartsafe are acclaimed for overseeing operations of a Nuclear Cardiology laboratory that was first-in-the-area to be accredited by the Intersocietal Accreditation Commission. At Heartsafe, his chief goal is to provide exceptional care without exception. He graduated with honors from a liberal arts college in North Texas, Austin College. He then acquired a medical degree from The Medical College of Wisconsin - Marquette University. Subsequently, Dr. Dohadwala decided to move to the Boston area to further pursue and explore the fascinating field of cardiovascular medicine as well as establish personal roots in a diverse and worldly community. At Boston University-Boston Medical Center, he completed his internship and residency in internal medicine, was awarded the Ruth L. Kirschstein National Research Service Award in vascular medicine, and finished his fellowship in cardiovascular medicine. He is board-certified in Internal Medicine, Cardiovascular Disease and Nuclear Cardiology. Dr. Dohadwala is a Member of the American College of Cardiology, the Lawrence General Hospital Quality Assurance Committee, and the Merrimack Valley Chamber of Commerce. Winning research awards and authoring a number of original scientific as well as review articles on the subject of human vascular health, he remains passionate about new discovery and advancement in cardiovascular science. His interest includes Systemic atherosclerosis (hardening and thickening of the blood vessels), Valvular heart disease (leaky and/or tight heart valves), Pulmonary hypertension (high pressures of the blood vessels in the lungs), Clinical electrophysiology (heart rhythm disorders), Cardiovascular imaging, and Preventive health and nutrition. Coming from an academic background, he remains interested in the instruction of medical students, physicians-in-training, nurses and other healthcare professionals.
Dr. Erich Cosmi is an Associate Professor of division of Obstetrics and Gynecology at University of Padua School of Medicine in Italy. Dr. cosmi performed Reviwes in Placenta, British Journal of Obstetrics and Gynecology (BJOG), Indian Journal of Medical Sciences, Pediatrics International, Human Reproduction, The American Journal of Obstetrics and Gynecology, European Journal of Obstetrics and Gynecology and so on. He is a Member of the society of Ultrasound in Obstetrics and Gynecology from 2000 and Member of The AmericanInstitute of Ultrasound in Medicine from 2005. He received 'UgoTropea' prize for the best communication in Obstetrics,Best Communication 'International Society of
Dr. Erich Cosmi is an Associate Professor of division of Obstetrics and Gynecology at University of Padua School of Medicine in Italy. Dr. cosmi performed Reviwes in Placenta, British Journal of Obstetrics and Gynecology (BJOG), Indian Journal of Medical Sciences, Pediatrics International, Human Reproduction, The American Journal of Obstetrics and Gynecology, European Journal of Obstetrics and Gynecology and so on. He is a Member of the society of Ultrasound in Obstetrics and Gynecology from 2000 and Member of The AmericanInstitute of Ultrasound in Medicine from 2005. He received 'UgoTropea' prize for the best communication in Obstetrics,Best Communication 'International Society of Ultrasound in Obstetrics and Gynecology' from Hamburg and Los Angeles, USA. His area of expertise consists of IUGR, Fetal anemia, Fetalhydrops, Fetal Doppler, Maternal and Fetal Medicine, FetalTeraphy, Twins, Endometriosis.
Anastase DZUDIE, MD; FESC is a consultant cardiologist and lecturer at Buea Faculty of Health Sciences, Cameroon. He is co-chair of the board of the Clinical Research Education, Networking and Consultancy (CRENC). In 2004, Dr DZUDIE graduated as an internal medicine physician in Cameroon. He further trained in general cardiology, cardiac echography and cardiac pacing at Louis Pradel's cardiovascular hospital and Claude Bernard University Lyon, France. He is chair of the task force on hypertension of the Pan-African Society of Cardiology and Regional Editor of the Cardiovascular Journal of Africa. He was among the 2014 emerging leaders of the World
Anastase DZUDIE, MD; FESC is a consultant cardiologist and lecturer at Buea Faculty of Health Sciences, Cameroon. He is co-chair of the board of the Clinical Research Education, Networking and Consultancy (CRENC). In 2004, Dr DZUDIE graduated as an internal medicine physician in Cameroon. He further trained in general cardiology, cardiac echography and cardiac pacing at Louis Pradel's cardiovascular hospital and Claude Bernard University Lyon, France. He is chair of the task force on hypertension of the Pan-African Society of Cardiology and Regional Editor of the Cardiovascular Journal of Africa. He was among the 2014 emerging leaders of the World Heart Federation. He has co-authored over 50 peer-reviewed publications and participated in several international collaborative research programs. His current research focus include systemic hypertension and clinical pathways from heart failure to pulmonary hypertension due to left heart diseases. He has special interest in setting and addressing the top cardiovascular priorities in Africa.
Dr. Hassan H. Musa is Associate Professor at Faculty of Medical Laboratory Sciences (FMLSs), University of Khartoum, Sudan. He received his PhD in Molecular Genetics and two years Postdoctoral Research fellow in Molecular Immunology from Yangzhou University (China). He also trained in Stem cell biology at the National Institute of Genetic Engineering and Biotechnology (Iran), and in Immunology and Genetics at the School of Medicine, University of Pennsylvania (USA). He is a founder of the Institute of Molecular Biology at University of Nyala, and currently Supervisor of Biomedical Research Laboratory at FMLSs, University of Khartoum. He is leading a multidisciplinary
Dr. Hassan H. Musa is Associate Professor at Faculty of Medical Laboratory Sciences (FMLSs), University of Khartoum, Sudan. He received his PhD in Molecular Genetics and two years Postdoctoral Research fellow in Molecular Immunology from Yangzhou University (China). He also trained in Stem cell biology at the National Institute of Genetic Engineering and Biotechnology (Iran), and in Immunology and Genetics at the School of Medicine, University of Pennsylvania (USA). He is a founder of the Institute of Molecular Biology at University of Nyala, and currently Supervisor of Biomedical Research Laboratory at FMLSs, University of Khartoum. He is leading a multidisciplinary research projects in Genetics, Immunology, and Stem Cell, with special interest in Cardio-metabolic Disease (Coronary artery disease, stroke, diabetes and hypertension) in case-control Sudanese population. He also has special interest in capacity building for Young Scientists.
Dr. Gupta is an Assistant Professor of Biopharmaceutical Sciences at School of Pharmacy, Keck Graduate Institute in California. Dr. Gupta received a B.S. in pharmaceutical sciences from JamiaHamdard (University) in New Delhi, India; and a PhD in Pharmaceutical Sciences from School of Pharmacy, Texas Tech University Health Sciences Center, USA. He completed his postdoctoral training at University of California Santa Barbara (UCSB). Dept. of Chemical Engineering. Dr. Gupta's current research is focused at developing therapeutic regimens for various respiratory and cardiopulmonary diseases including Pulmonary Arterial Hypertension (PAH), and idiopathic pulmonary fibrosis (IPF). He is seeking
Dr. Gupta is an Assistant Professor of Biopharmaceutical Sciences at School of Pharmacy, Keck Graduate Institute in California. Dr. Gupta received a B.S. in pharmaceutical sciences from JamiaHamdard (University) in New Delhi, India; and a PhD in Pharmaceutical Sciences from School of Pharmacy, Texas Tech University Health Sciences Center, USA. He completed his postdoctoral training at University of California Santa Barbara (UCSB). Dept. of Chemical Engineering. Dr. Gupta's current research is focused at developing therapeutic regimens for various respiratory and cardiopulmonary diseases including Pulmonary Arterial Hypertension (PAH), and idiopathic pulmonary fibrosis (IPF). He is seeking new novel small molecules for treating PAH and IPF; and is also looking into developing targeted drug delivery systems for localizing therapies into pulmonary vascular endothelium.
Dr. Zohi (Zohara) Sternberg is an Assistant Professor of Department of Neurology and Neurosurgery at University of Buffalo in Buffalo, NY. Dr. Sternberg is a translational research scientist with expertise in CNS (multiple sclerosis, ischemic stroke, Alzheimer's disease) and Vascular/ Metabolic (atherosclerosis/ vascular diseases, hypercholesterolemia, diabetes) disorders. Her research interests include Biomarkers of inflammation and neurodegeneration in multiple sclerosis, and Alzheimer's disease, Autonomic dysfunction as it applies to autoimmune and neurodegenerative diseases Inflammation, platelet function, and antiplatelet resistance in ischemic stroke Vascular disease in autoimmune and neurodegenerative diseases, Mechanisms of action of drugs to treat vascular/ metabolic diseases-genomic differences.
Dr. Zohi (Zohara) Sternberg is an Assistant Professor of Department of Neurology and Neurosurgery at University of Buffalo in Buffalo, NY. Dr. Sternberg is a translational research scientist with expertise in CNS (multiple sclerosis, ischemic stroke, Alzheimer's disease) and Vascular/ Metabolic (atherosclerosis/ vascular diseases, hypercholesterolemia, diabetes) disorders. Her research interests include Biomarkers of inflammation and neurodegeneration in multiple sclerosis, and Alzheimer's disease, Autonomic dysfunction as it applies to autoimmune and neurodegenerative diseases Inflammation, platelet function, and antiplatelet resistance in ischemic stroke Vascular disease in autoimmune and neurodegenerative diseases, Mechanisms of action of drugs to treat vascular/ metabolic diseases-genomic differences.
Dr.Ahmed is currently an Assistant-professor of Pharmacology and Toxicology at the Faculty of Pharmacy in Alexandria University. Previously, he was a Canadian Institutes for Health Research Fellow at the Faculty of Medicine in the University of Calgary, and a licensed Clinical Pharmacist/Pharmacy owner of two ambulatory hospital pharmacies in Calgary, Alberta, Canada. Ahmed graduated from the Faculty of Pharmacy, Alexandria University, Egypt in June 2001 with top honors. He moved on to get his PhD degree in Pharmacology from the University of Alberta in Edmonton, Alberta, Canada, which was awarded in 2008.
Dr.Ahmed is currently an Assistant-professor of Pharmacology and Toxicology at the Faculty of Pharmacy in Alexandria University. Previously, he was a Canadian Institutes for Health Research Fellow at the Faculty of Medicine in the University of Calgary, and a licensed Clinical Pharmacist/Pharmacy owner of two ambulatory hospital pharmacies in Calgary, Alberta, Canada. Ahmed graduated from the Faculty of Pharmacy, Alexandria University, Egypt in June 2001 with top honors. He moved on to get his PhD degree in Pharmacology from the University of Alberta in Edmonton, Alberta, Canada, which was awarded in 2008.
Robert Michael Davidson completed his Ph.D. in Pharmaceutical Chemistry at the age of 26 from UCSF, NSF postdoctoral fellowship at the National Bureau of Standards, Center for Analytical Chemistry, M.D. degree at St Louis University School of Medicine, Nuclear Medicine residency at Baylor College of Medicine, Houston, Texas, and Internal Medicine residency in Phoenix, Arizona. He was Associate Medical Director for DuPont Pharma's Radiopharmaceutical Division 1990-1992. He has published more than 30 papers in peer-reviewed journals. He is a Fellow of The American Institute of Stress (2012-present) and formerly practicing complementary/alternative/integrative internal medicine in Gladewater, Texas (USA), recently retired
Robert Michael Davidson completed his Ph.D. in Pharmaceutical Chemistry at the age of 26 from UCSF, NSF postdoctoral fellowship at the National Bureau of Standards, Center for Analytical Chemistry, M.D. degree at St Louis University School of Medicine, Nuclear Medicine residency at Baylor College of Medicine, Houston, Texas, and Internal Medicine residency in Phoenix, Arizona. He was Associate Medical Director for DuPont Pharma's Radiopharmaceutical Division 1990-1992. He has published more than 30 papers in peer-reviewed journals. He is a Fellow of The American Institute of Stress (2012-present) and formerly practicing complementary/alternative/integrative internal medicine in Gladewater, Texas (USA), recently retired (June 2015).
Dr. Yano is Assistant Professor at Duke University, Durham, USA. He received his MD degree (2002) and PhD degree (2014) from Jichi Medical School, Tochigi, Japan. Dr. Yano has been engaging in blood pressure (BP) observational and interventional research for 13 years. He has a strong interest in detailed phenotyping of BP based on ambulatory BP values. His research focus is short/long-term BP variability, including nocturnal BP and diurnal BP variation.
Dr. Yano is Assistant Professor at Duke University, Durham, USA. He received his MD degree (2002) and PhD degree (2014) from Jichi Medical School, Tochigi, Japan. Dr. Yano has been engaging in blood pressure (BP) observational and interventional research for 13 years. He has a strong interest in detailed phenotyping of BP based on ambulatory BP values. His research focus is short/long-term BP variability, including nocturnal BP and diurnal BP variation.
Dr. Sasikanth Adigopula is an Advanced Heart Failure Cardiologist, Director of Heart Failure at Regional Medical Center and Assistant Professor in the Division of Cardiology at Loma Linda University. He completed his training at Stanford University and University of California at Los Angeles. He has authored many important papers and book chapters. He has published in prestigious medical journals including New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, American Heart Journal, American Journal of Cardiology, Journal of American Society of Echocardiography and International Journal of Cardiovascular Imaging. He has received many national and international awards,
Dr. Sasikanth Adigopula is an Advanced Heart Failure Cardiologist, Director of Heart Failure at Regional Medical Center and Assistant Professor in the Division of Cardiology at Loma Linda University. He completed his training at Stanford University and University of California at Los Angeles. He has authored many important papers and book chapters. He has published in prestigious medical journals including New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, American Heart Journal, American Journal of Cardiology, Journal of American Society of Echocardiography and International Journal of Cardiovascular Imaging. He has received many national and international awards, recognition and grants for his clinical and research work. He has presented his research in many national and international Cardiology conferences. He serves on the Editorial board of many peer-reviewed medical journals. He is dedicated to academics, teaching, patient care, research in advance heart failure and advancement in medicine. He is a member of American Heart Association, American College of Cardiology, International Society for Heart and Lung Transplantation, American Society of Echocardiography, Heart Failure Society of America, American Society of Nuclear Medicine and American Medical Association. Dr. Adigopula is a Fellow in the American College of Cardiology and the American College of Physicians. His research interest includes stem cell therapy in heart failure and clinical outcomes in advanced heart failure. His personal interests include piano, tennis and soccer but most importantly spending time with his young children. In his spare time, he volunteers in a free medical clinic and promotes charitable organizations such as UNICEF and Red Cross. Dr. Sasikanth Adigopula research interests include stem cell therapy in Heart Failure, clinical outcomes in Advanced Heart Failure and Immunology in Heart Transplantation.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97